YB
Yasmine Baca
Caris Life Sciences Inc Phoenix
Research areas: Medicine · Oncology · Cancer Genomics and Diagnostics · Cancer Immunotherapy and Biomarkers · Pancreatic and Hepatic Oncology Research
0000-0003-2130-0611
About
Phd candidate in bioinformatics working in clinical and translational research at Caris Life Sciences.
Employment
-
Caris Life Sciences Inc Phoenix Molecular Research Analyst2019 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (38)
- Spatial Transcriptomics on a Diverse Pancreatic Cancer Cohort Reveals Race-Related Differences in Tumor Subtypes and Immune Microenvironments Save
- Molecular alteration profiles characterize intraductal carcinoma of the prostate Save
- Data from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Figure S1 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Figure S2 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Figure S3 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Figure S4 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Figure S5 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Figure S6 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Figure S7 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Table S1 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Table S2 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Supplementary Table S3 from XPO1R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance Save
- Data from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma Save
- Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma Save
- Supplementary Table S1 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma Save
- Supplementary Table S2 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma Save
- Supplementary Table S3 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma Save
- Supplementary Table S4 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma Save